Purespring Therapeutics

Developer of therapeutics for chronic renal diseases

placeLondon, England, United Kingdom calendar_todayFounded 2020 groups50 employees language purespringtx.com

Registered entities

Innovation

22 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport; filing pace accelerating. Cited 559 times.

YearFilings
20222
20238
20247
202514
20264

Social engagement

Social engagement: 8.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Sofinnova Partners, Syncona.

Investor typeCountShare
Venture capital480%
Private equity120%

Recent activity

17 Jun 2026
Event
BIO International Convention
21 May 2026
Recognition
27 Mar 2026
Recognition
Coming soon